MphB (macrolide 2'-phosphotransferase II, MPH(2')II) is a plasmid-encoded macrolide kinase that inactivates macrolide antibiotics. It transfers the gamma-phosphate of a purine nucleoside triphosphate (ATP, GTP or ITP) to the 2'-hydroxyl group of the desosamine sugar of macrolides, producing an inactive macrolide 2'-O-phosphate that can no longer bind the bacterial ribosome; this enzymatic detoxification confers macrolide resistance. MphB acts on a broad range of substrates spanning 14-membered (e.g. oleandomycin, erythromycin, clarithromycin, roxithromycin, dirithromycin), 15-membered (azithromycin), and 16-membered (e.g. spiramycin, tylosin, josamycin) macrolides as well as the ketolide telithromycin (CARD ARO:3000318). Early phenotyping placed MphB as relatively narrow (with azithromycin resistance attributed specifically to MphA), but later enzymatic and mass-spectrometric work showed MphB inactivates essentially all macrolides tested, including azithromycin and telithromycin. The cloned mphB encodes a 302-residue, ~34.5 kDa protein matching this UniProt entry exactly. Crystal structures of the MphB class (MPH(2')-II) reveal the bi-lobed protein-kinase-like fold of the aminoglycoside phosphotransferase (APH) superfamily, distinguished by a large interdomain linker that forms an expanded, largely hydrophobic macrolide-binding pocket; nucleotide is bound in the kinase pocket (structures captured with GTP analogs, and GTP is a preferred donor in vitro, though ATP, GTP and ITP can all serve). Catalysis depends on conserved active-site residues β aspartates D200/D209/D219/ D231 and the conserved His205 β and on a divalent metal (activity is EDTA-inhibited), consistent with the Mg2+-dependent phosphotransfer chemistry of this fold; D227 contributes to recognition of 16-membered macrolides. In this organism the gene is carried on plasmid pO83_CORR of the adherent-invasive Escherichia coli strain NRG 857C, making it part of the mobile macrolide-resistance gene pool of enteric bacteria.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0050073 macrolide 2'-kinase activity | IDA PMID:1330822 Purification and characterization of macrolide 2'-phosphotra... | NEW | Summary: MphB phosphorylates the 2'-OH of macrolides using a purine NTP, producing inactive macrolide 2'-O-phosphate. This is the core, experimentally demonstrated molecular function and exactly matches the GO:0050073 definition (ATP + oleandomycin = ADP + 2 H+ + oleandomycin 2'-O-phosphate). Reason: The purified enzyme was shown biochemically to phosphorylate macrolides at the 2'-position, and the product was identified as oleandomycin 2'-phosphate by TLC; the mechanism (gamma-phosphate transfer from ATP to the macrolide 2'-OH) and catalytic aspartates were confirmed by mutagenesis. No curated GOA annotation exists for this TrEMBL entry, so this specific MF should be added. Supporting Evidence: PMID:1330822 Inactivated oleandomycin was identified as oleandomycin 2'-phosphate by thin-layer chromatography. PMID:10428938 transfers the gamma phosphate of ATP to the 2'-OH group of macrolide antibiotics. PMID:29317655 Using tandem mass spectrometry, we also confirmed that MphB phosphorylates the desosamine 2β²-OH of erythromycin |
| GO:0046677 response to antibiotic | IMP PMID:9503630 Expression of the mphB gene for macrolide 2'-phosphotransfer... | NEW | Summary: By enzymatically inactivating macrolides, MphB confers macrolide antibiotic resistance; expression of mphB renders host bacteria resistant to 14-, 15- and 16-membered macrolides (e.g. high-level spiramycin resistance when expressed in S. aureus). Reason: Resistance is the biological process in which this enzyme participates: mphB expression confers macrolide resistance in both E. coli and a heterologous host. "response to antibiotic" is the standard, well-supported BP for an antibiotic-modifying resistance enzyme. (Note: phosphorylation inactivates/modifies rather than degrades the drug, so an "antibiotic catabolic process" term would be less accurate.) Supporting Evidence: PMID:9503630 The gene endowed S. aureus with high-level resistance to spiramycin, a macrolide antibiotic with a 16-membered ring. PMID:9503630 The genes mphA and mphB encode macrolide 2'-phosphotransferases I and II, respectively, and they confer resistance to macrolide antibiotics in Escherichia coli. PMID:29317655 we found that MphB confers resistance to all macrolides tested...and inactivates both telithromycin and azithromycin PMID:17302923 The mph(C) gene, as reported for mph(B), also conferred resistance to spiramycin...The four investigated genes conferred resistance to telithromycin. |
| GO:0005737 cytoplasm | IDA PMID:1330822 Purification and characterization of macrolide 2'-phosphotra... | NEW | Summary: MphB was characterized as a soluble, intracellular (cytoplasmic) enzyme upon purification from E. coli, consistent with cytoplasmic detoxification of macrolides before they reach the ribosome. Reason: The purified enzyme was reported as a constitutive intracellular enzyme, indicating cytoplasmic localization β the expected compartment for a soluble macrolide-inactivating kinase. Supporting Evidence: PMID:1330822 MPH(2')II was a constitutive intracellular enzyme |
Loading supporting contentβ¦
Download this section (compressed HTML)Q: Does the plasmid-borne mphB in this AIEC strain (NRG 857C) contribute meaningfully to clinical macrolide resistance in vivo, and is its expression constitutive or induced under macrolide exposure?
Q: Is the in vitro preference for GTP over ATP as phosphate donor (seen structurally) physiologically relevant in the cell, where ATP is far more abundant than GTP?
Experiment: Measure steady-state kinetics (kcat/Km) of purified MphB against a panel of 14-, 15- and 16-membered macrolides and ketolides, comparing ATP vs GTP/ITP donors, to quantify substrate and cofactor preferences.
Experiment: Construct an mphB deletion in E. coli O83:H1 NRG 857C and measure MICs across macrolides/ketolides to quantify the gene's contribution to resistance in its native genetic background.
Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)